Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 15: | Line 15: | ||
=====Anti-myeloma===== | =====Anti-myeloma===== | ||
* [[Bortezomib]] - Generic: Velcade | * [[Bortezomib]] - Generic: Velcade | ||
| + | =====Anti-acute lymphocytic leukemia===== | ||
| + | * [[Imatinib]] - Generic: Gleevec; See [[Treatment of acute lymphocytic leukemia]] | ||
=====Anti-non-small cell lung cacinoma===== | =====Anti-non-small cell lung cacinoma===== | ||
* [[Afatinib]] - Generic: Gilotrif; See [[Treatment non-small cell lung carcinoma]] | * [[Afatinib]] - Generic: Gilotrif; See [[Treatment non-small cell lung carcinoma]] | ||
Revision as of 08:50, 8 January 2025
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
Anti-prostate cancer
Anti-myeloma
Anti-acute lymphocytic leukemia
Anti-non-small cell lung cacinoma
B-Raf Kinase Inhibitor
ChemotherapyDihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitors
Estrogen Receptor Modulator
mTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl, RAF kinase) Inhibitors
Vascular Endothelial Growth Factor Inhibitor
Poly ADP ribose polymerase (PARP) inhibitorsCyclin-dependent kinases inhibitors
See also Anti-cancer drugs, Anticancer drugs and RAF kinase inhibitors |
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
